Sensitivity and specificity of the empirical lymphocyte genome sensitivity (LGS) assay: Implications for improving cancer diagnostics

FASEB Journal

Volumn 28, Issue 10, 2014, Pages 4563-4570

  Anderson, Diana ^a   Najafzadeh, Mojgan ^a   Gopalan, Rajendran ^a   Ghaderi, Nader ^a   Scally, Andrew J ^a   Britland, Stephen T ^b   Jacobs, Badie K ^c   Reynolds, P Dominic ^c   Davies, Justin ^c   Wright, Andrew L ^c   Al Ghazal, Shariff ^c   Sharpe, David ^c   Denyer, Morgan C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^c BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

Blood test; Susceptibility

Indexed keywords

ADULT; AGED; ARTICLE; BIOASSAY; CANCER DIAGNOSIS; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLON CANCER; COMET ASSAY; CONTROLLED STUDY; CYTOMETRY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; INVESTIGATIVE PROCEDURES; LUNG CANCER; LYMPHOCYTE GENOME SENSITIVITY ASSAY; MAJOR CLINICAL STUDY; MALE; MELANOMA; POLYPOSIS; PRECANCER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET A RADIATION; ADOLESCENT; CASE CONTROL STUDY; EARLY DIAGNOSIS; EVALUATION STUDY; HUMAN GENOME; LYMPHOCYTE; MIDDLE AGED; NEOPLASMS; PROCEDURES; RADIATION DOSE; RADIATION RESPONSE; STATISTICAL ANALYSIS; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; EARLY DETECTION OF CANCER; FEMALE; GENOME, HUMAN; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; RADIATION TOLERANCE; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RAYS;

EID: 84907696938     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-254748     Document Type: Article

References (48)

1. Cancer Research UK (n.d.) Lifetime risk of cancer. Retrieved from http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/risk/statistics-on-the-risk-of-developing-cancer
2. Franks, P. J., and Bosanquet, N. (2004) Cost-effectiveness: Seeking value for money in lower extremity wound management. Int. J. Low. Extrem. Wounds 3, 87-95
3. UK Office for National Statistics (2012, June 13) Cancer Statistics Regulations, England (Series MB1), No 41, 2010. Retrieved from http://www.ons.gov.uk/ons/dcp171778-267154.pdf
4. Hoyert, D. L., Mathews, T. J., Menacker, F., Strobino, D. M., and Guyer, B. (2006) Annual summary of vital statistics: 2004. Pediatrics 117, 168-183
5. Mariotto, A. B., Yabroff, K. R., Shao, Y., Feuer, E. J., and Brown, M. L. (2011) Projections of the cost of cancer care in the United States: 2010-2020. J. Natl. Cancer Inst. 103, 117-128
6. Austoker, J. (1994) Cancer prevention in primary care: Current trends and some prospects for the future. II. BMJ 309, 517-520
7. Tsui, K. H., Shvarts, O., Smith, R. B., Figlin, R. A., de Kernion, J. B., and Belldegrun, A. (2000) Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 163, 1090-1095; quiz 1295
8. Shridhar, V., Lee, J., Pandita, A., Iturria, S., Avula, R., Staub, J., Morrissey, M., Calhoun, E., Sen, A., Kalli, K., Keeney, G., Roche, P., Cliby, W., Lu, K., Schmandt, R., Mills, G. B., Bast, R. C., Jr., James, C. D., Couch, F. J., Hartmann, L. C., Lillie, J., and Smith, D. I. (2001) Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res. 61, 5895-5904
9. Curt, G. A., Breitbart, W., Cella, D., Groopman, J. E., Horning, S. J., Itri, L. M., Johnson, D. H., Miaskowski, C., Scherr, S. L., Portenoy, R. K., and Vogelzang, N. J. (2000) Impact of cancerrelated fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 5, 353-360
10. Katz, M. R., Irish, J. C., Devins, G. M., Rodin, G. M., and Gullane, P. J. (2003) Psychosocial adjustment in head and neck cancer: The impact of disfigurement, gender and social support. Head Neck 25, 103-112
11. Boinon, D., Sultan, S., Charles, C., Stulz, A., Guillemeau, C., Delaloge, S., and Dauchy, S. (2014) Changes in psychological adjustment over the course of treatment for breast cancer: The predictive role of social sharing and social support. Psychooncology 23, 291-298
12. Luker, K., Campbell, M., Amir, Z., and Davies, L. (2013) A UK survey of the impact of cancer on employment. Occup. Med. 63, 494-500
13. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., 3rd, Johnson, B. E., and Skolnick, M. H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436-440
14. Poeta, M. L., Massi, E., Parrella, P., Pellegrini, P., De Robertis, M., Copetti, M., Rabitti, C., Perrone, G., Muda, A. O., Molinari, F., Zanellato, E., Crippa, S., Caputo, D., Caricato, M., Frattini, M., Coppola, R., and Fazio, V. M. (2012) Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors. Genes Chromosomes Cancer 51, 1133-1143
15. Chimonidou, M., Tzitzira, A., Strati, A., Sotiropoulou, G., Sfikas, C., Malamos, N., Georgoulias, V., and Lianidou, E. (2013) CST6 promoter methylation in circulating cell-free DNA of breast cancer patients. Clin. Biochem. 46, 235-240
16. Bai, J., Mei, P. J., Liu, H., Li, C., Li, W., Wu, Y. P., Yu, Z. Q., and Zheng, J. N. (2012) BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro. J. Cancer Res. Clin. Oncol. 138, 991-998
17. Leszinski, G., Gezer, U., Siegele, B., Stoetzer, O., and Holdenrieder, S. (2012) Relevance of histone marks H3K9me3 and H4K20me3 in cancer. Anticancer Res. 32, 2199-2205
18. Chen, X., Hu, Z., Wang, W., Ba, Y., Ma, L., Zhang, C., Wang, C., Ren, Z., Zhao, Y., Wu, S., Zhuang, R., Zhang, Y., Hu, H., Liu, C., Xu, L., Wang, J., Shen, H., Zhang, J., Zen, K., and Zhang, C. Y. (2012) Identification of ten serum microRNAs from a genomewide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int. J. Cancer 130, 1620-1628
19. Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., McAllister, P. K., Morton, R. F., and Schilsky, R. L. (2009) American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J. Clin. Oncol. 27, 2091-2096
20. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. (2002) Mutations of the BRAF gene in human cancer. Nature 417, 949-954
21. Collins, A. R. (2004) The comet assay for DNA damage and repair: Principles, applications, and limitations. Mol. Biotechnol. 26, 249-261
22. Neel, J. V., Schull, W. J., Awa, A. A., Satoh, C., Otake, M., Kato, H., and Yoshimoto, Y. (1989) Implications of the Hiroshima-Nagasaki genetic studies for the estimation of the human "doubling dose" of radiation. Genome 31, 853-859
23. Albertini, R. J., Anderson, D., Douglas, G. R., Hagmar, L., Hemminki, K., Merlo, F., Natarajan, A. T., Norppa, H., Shuker, D. E., Tice, R., Waters, M. D., and Aitio, A. (2000) IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat. Res. 463, 111-172
24. Ahmadzadeh, M., Johnson, L. A., Heemskerk, B., Wunderlich, J. R., Dudley, M. E., White, D. E., and Rosenberg, S. A. (2009) Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537-1544
25. Balkwill, F., and Mantovani, A. (2001) Inflammation and cancer: back to Virchow? Lancet 357, 539-545
26. Ben-Baruch, A. (2006) Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators. Semin. Cancer Biol. 16, 38-52
27. Wang, X., Werneck, M. B., Wilson, B. G., Kim, H. J., Kluk, M. J., Thom, C. S., Wischhusen, J. W., Evans, J. A., Jesneck, J. L., Nguyen, P., Sansam, C. G., Cantor, H., and Roberts, C. W. (2011) TCR-dependent transformation of mature memory phenotype T cells in mice. J. Clin. Invest. 121, 3834-3845
28. Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., and Iacopetta, B. (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J. Clin. Oncol. 27, 186-192
29. Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., Nagtegaal, I. D., Palmqvist, R., Masucci, G. V., Botti, G., Tatangelo, F., Delrio, P., Maio, M., Laghi, L., Grizzi, F., Asslaber, M., D'Arrigo, C., Vidal-Vanaclocha, F., Zavadova, E., Chouchane, L., Ohashi, P. S., Hafezi-Bakhtiari, S., Wouters, B. G., Roehrl, M., Nguyen, L., Kawakami, Y., Hazama, S., Okuno, K., Ogino, S., Gibbs, P., Waring, P., Sato, N., Torigoe, T., Itoh, K., Patel, P. S., Shukla, S. N., Wang, Y., Kopetz, S., Sinicrope, F. A., Scripcariu, V., Ascierto, P. A., Marincola, F. M., Fox, B. A., and Pages, F. (2014) Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J. Pathol. 232, 199-209
30. Osipov, A. N., Smetanina, N. M., Pustovalova, M. V., Arkhangelskaya, E., and Klokov, D. (2014) The formation of DNA singlestrand breaks and alkali-labile sites in human blood lymphocytes exposed to 365-nm UVA radiation. Free Radic. Biol. Med. 73C, 34-40
31. Jiang, Y., Rabbi, M., Kim, M., Ke, C., Lee, W., Clark, R. L., Mieczkowski, P. A., and Marszalek, P. E. (2009) UVA generates pyrimidine dimers in DNA directly. Biophys. J. 96, 1151-1158
32. Ikehata, H., Kumagai, J., Ono, T., and Morita, A. (2013) Solar-UV-signature mutation prefers TCG to CCG: extrapolative consideration from UVA1-induced mutation spectra in mouse skin. Photochem. Photobiol. Sci. 12, 1319-1327
33. Cortat, B., Garcia, C. C., Quinet, A., Schuch, A. P., de Lima-Bessa, K. M., and Menck, C. F. (2013) The relative roles of DNA damage induced by UVA irradiation in human cells. Photochem. Photobiol. Sci. 12, 1483-1495
34. Svobodova, A. R., Galandakova, A., Sianska, J., Dolezal, D., Lichnovska, R., Ulrichova, J., and Vostalova, J. (2012) DNA damage after acute exposure of mice skin to physiological doses of UVB and UVA light. Arch. Dermatol. Res. 304, 407-412
35. Wischermann, K., Popp, S., Moshir, S., Scharfetter-Kochanek, K., Wlaschek, M., de Gruijl, F., Hartschuh, W., Greinert, R., Volkmer, B., Faust, A., Rapp, A., Schmezer, P., and Boukamp, P. (2008) UVA radiation causes DNA strand breaks, chromosomal aberrations and tumorigenic transformation in HaCaT skin keratinocytes. Oncogene 27, 4269-4280
36. Greinert, R., Volkmer, B., Henning, S., Breitbart, E. W., Greulich, K. O., Cardoso, M. C., and Rapp, A. (2012) UVA-induced DNA double-strand breaks result from the repair of clustered oxidative DNA damages. Nucleic Acids Res. 40, 10263-10273
37. Dhawan, A., and Anderson, D., eds. (2009) The Comet Assay in Toxicology. Issues in Toxicology No. 5, Royal Society of Chemistry, London
38. Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J. C., and Sasaki, Y. F. (2000) Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35, 206-221
39. Singh, N. P., McCoy, M. T., Tice, R. R., and Schneider, E. L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191
40. Sharpe, D. T. Denyer, M. C. T., Anderson, D., Britland, S. T., and Gopalan, R., inventors; University of Bradford, Sharpe, D. T. Denyer, M. C. T., Anderson, D., Britland, S. T., and Gopalan, R., applicants (2008, May 2) Assay and method. World patent application WO2008050134A2
41. Anderson, D., Britland, S. T., Denyer, M. C. T., Gopalan, R., and Sharpe, D. T., inventors; Anderson, D., Britland, S. T., Denyer, M. C. T., Gopalan, R., Sharpe, D. T., and University of Bradford, applicants (2008, July 3) Assay and method. World patent application WO2008050134A3
42. Kumaravel, T. S., Vilhar, B., Faux, S. P., and Jha, A. N. (2009) Comet assay measurements: a perspective. Cell Biol. Toxicol. 25, 53-64
43. Kumaravel, T. S., and Jha, A. N. (2006) Reliable comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat. Res. 605, 7-16
44. Hartmann, A., Agurell, E., Beevers, C., Brendler-Schwaab, S., Burlinson, B., Clay, P., Collins, A., Smith, A., Speit, G., Thybaud, V., and Tice, R. R. (2003) Recommendations for conducting the in vivo alkaline comet assay. 4th International Comet Assay Workshop. Mutagenesis 18, 45-51
45. Lovell, D. P., Thomas, G., and Dubow, R. (1999) Issues related to the experimental design and subsequent statistical analysis of in vivo and in vitro comet studies. Teratog. Carcinog. Mutagen. 19, 109-119
46. Hanley, J. A., and McNeil, B. J. (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36
47. Pepe, M. S., Longton, G., Anderson, G. L., and Schummer, M. (2003) Selecting differentially expressed genes from microarray experiments. Biometrics 59, 133-142
48. Najafzadeh, M., Baumgartner, A., Gopalan, R., Davies, J. B., Wright, A., Reynolds, P. D., and Anderson, D. (2012) In vitro sensitivities to UVA of lymphocytes from patients with colon and melanoma cancers and precancerous states in the micronucleus and the comet assays. Mutagenesis 27, 351-357